Evotec SE (EVO) Cash from Operations (QoQ) (2009 - 2026)
Evotec SE (EVO) Cash from Operations (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.96% |
| Dec 31, 2025 | -13,321.49% |
| Sep 30, 2025 | -362.73% |
| Jun 30, 2025 | 189.84% |
| Mar 31, 2025 | -100.17% |
| Dec 31, 2024 | 41,645.14% |
| Sep 30, 2024 | 186.16% |
| Jun 30, 2024 | -3.75% |
| Mar 31, 2024 | -100.13% |
| Dec 31, 2023 | 163,013.90% |
| Sep 30, 2023 | 455.80% |
| Jun 30, 2023 | -1,104.96% |
| Mar 31, 2023 | -100.00% |
| Dec 31, 2022 | 5,234,511.61% |
| Sep 30, 2022 | -102.12% |
| Jun 30, 2022 | 164.50% |
| Mar 31, 2022 | -99.95% |
| Dec 31, 2021 | 590,118.13% |
| Sep 30, 2021 | -50.45% |
| Jun 30, 2021 | 1,668,691.98% |